Atlas Venture Associates Opportunity I, L.P.
CIK 000178006510% Owner
Filings
7
Latest Mar 13, 2024
Issuers covered
4
Showing
7 of 7
Page 1
Issuers
Companies where Atlas Venture Associates Opportunity I, L.P. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| IRON | Disc Medicine, Inc. | 2 | Jan 25, 2024 |
| DYN | Dyne Therapeutics, Inc. | 2 | Feb 28, 2024 |
| XLO | Xilio Therapeutics, Inc. | 2 | Feb 9, 2024 |
| KYMR | Kymera Therapeutics, Inc. | 1 | Mar 13, 2024 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Issuer | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 13, 2024 | KYMRKymera Therapeutics, Inc. | S | 126,066 | $41.94 | $5,287,208 | |
| Feb 28, 2024 | DYNDyne Therapeutics, Inc. | S | 272,923 | $24.38 | $6,653,863 | |
| Feb 23, 2024 | DYNDyne Therapeutics, Inc. | S | 159,542 | $22.70 | $3,621,603 | |
| Feb 9, 2024 | XLOXilio Therapeutics, Inc. | S | 733 | $0.64 | $469 | |
| Jan 25, 2024 | IRONDisc Medicine, Inc. | S | 82,500 | $67.65 | $5,581,125 | |
| Jan 16, 2024 | XLOXilio Therapeutics, Inc. | S | 1,566 | $0.87 | $1,362 | |
| Jan 12, 2024 | IRONDisc Medicine, Inc. | S | 30,000 | $64.00 | $1,920,000 |
Showing 1–7 of 7
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.